Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Mobia Medical, Inc. appointed Myriam J. Curet, M.D., to its nominating and corporate governance committee, effective October 15, 2026. This filing is an amendment to a previous 8-K to finalize her committee assignment following her earlier election to the Board of Directors.
Mobia Medical, Inc. announced that the Board of Directors appointed Dr. Reza Zadno to its audit committee, effective October 15, 2026. Dr. Zadno, who was previously elected to the Board, will also continue to serve on the company's compensation committee.
Bank of Marin Bancorp announced that Brandi Campbell, Executive Vice President and Head of Retail Banking, has mutually agreed to terminate her employment effective October 16, 2026. Under a separation agreement, she will receive three months of lump-sum pay and nine months of COBRA premium reimbursements in exchange for a release of claims.
Sanjay Nayak, M.B.B.S., Ph.D., notified Ocular Therapeutix of his resignation as Chief Strategy Officer, effective October 16, 2026. Dr. Nayak is leaving the company to become the Chief Executive Officer of a privately-held company.
Quantum Cyber N.V. appointed Major General (Retired) Alberto C. Rosende to its Board of Directors, effective October 12, 2026. Maj. Gen. Rosende, who currently serves as CEO of M2i Global Inc., will also serve on the Audit, Compensation, and Nomination Committees. He brings nearly 40 years of U.S. Army command experience to the board and will receive the company's standard non-employee director compensation.
Michael C. Dennison is stepping down as CEO and resigning from the Board of Directors effective October 15, 2026. Independent director Douglas J. Grimm has been appointed Interim CEO while the Board initiates a search for a permanent successor. The transition occurs as the company reports preliminary Q3 results below expectations and updates its fiscal 2026 outlook.
AT&T Inc. filed an 8-K under Item 5.02 reporting a change in its leadership structure or board composition effective October 14, 2026. While the specific names and roles are detailed in the full filing exhibits, the disclosure triggers the requirement for reporting the appointment or departure of directors or certain senior officers.
Robert George has resigned as Chief Financial Officer of WidePoint Corporation, effective upon the filing of the company's Q3 2026 Form 10-Q. The resignation is for personal and family reasons and not due to any disagreement with the company. Mr. George will remain with the company in a non-officer capacity to assist with the transition of his responsibilities.
Jennifer L. Hamann, Executive Vice President and Chief Financial Officer of Union Pacific, plans to retire in early 2027 after a 35-year career with the company. She will maintain her current responsibilities until her retirement, and the company intends to announce succession plans at a later date.
Erasca, Inc. announced that Nicholas (Nik) Chetwyn, Ph.D., will step down as Chief Operating Officer effective November 2, 2026. The departure is part of a leadership realignment to streamline the company's reporting structure as it focuses on its RAS-targeting programs.
Change Agents Corporation appointed Eric Weisblum as an independent director to its board of directors, effective October 12, 2026. Mr. Weisblum, who is currently the CEO of Silo Pharma Inc, will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.
AutoNation, Inc. has appointed Mark Stewart to its Board of Directors as an independent director, effective October 13, 2026. Mr. Stewart, who currently serves as CEO and President of The Goodyear Tire & Rubber Company, will receive an annual Board retainer of $50,000 and be eligible for future equity awards.
Richard Lindahl will retire as CFO of Emergent BioSolutions effective December 31, 2026, remaining as an advisor through March 2027. Frank Vargo, the company's current VP and Treasurer, has been appointed Interim CFO effective January 1, 2027.
Ironwood Pharmaceuticals appointed Tammi Gaskins, currently Senior Vice President and Chief Commercial Officer, as Chief Executive Officer and a director, effective January 1, 2027. She succeeds Thomas McCourt, who will retire as CEO on December 31, 2026, after 17 years with the company but will remain on the Board of Directors. Gaskins will receive an annual base salary of $775,000 and $4 million in target equity grant value as part of her new role.
Truist Financial Corporation announced a major leadership reshuffle, including the departure of Dontá L. Wilson, Chief Consumer and Small Business Banking Officer, effective December 31, 2026. The company appointed D. Steve Boland as Vice Chair, Shimna Sameer as Chief Consumer Banking Officer, and Jeff Warner as Chief Small Business Banking Officer to drive its next phase of growth.
Kenneth T. Mills resigned from the board of directors of REGENXBIO Inc. effective October 21, 2026, to focus on his new role as CEO of another company. In response, the board appointed George Migausky as the new Chairman of the Board, while Daniel Tassé stepped down as Lead Independent Director but remains on the board.
Northann Corp. has elected Mr. Dat Nguyen to its Board of Directors, effective October 12, 2026, filling the vacancy left by the resignation of Mr. Lin Li. Mr. Nguyen, who brings over 20 years of technology consulting and leadership experience from firms like EY and Accenture, will serve on the Audit, Nomination, and Compensation Committees. This appointment restores the Board to its full complement of five members.
Jorge Bermudez retired from the Board of Directors effective October 12, 2026, after serving since 2011. In conjunction with his departure, Lisa Sawicki was appointed Chairman of the Audit Committee, and newly elected director Keith Demmings was appointed to the Governance & Nominating and Audit Committees effective November 1, 2026.
David Moatazedi, a member of the Board of Directors and Chairperson of the Compensation Committee, has determined not to stand for re-election at the company's 2026 Annual Meeting of Stockholders. His departure, effective December 11, 2026, is not due to any dispute or disagreement with the company. Mr. Moatazedi has served on the Biomerica board since December 2022.
Dr. Gorjan Hrustanovic resigned from the Board of Directors and its committees effective October 14, 2026, noting no disagreements with the company. Dr. Prakash Raman was subsequently appointed to the Compensation and Science and Technology Committees to fill the vacancies.
CD 2017-CD3 Mortgage Trust announced that Torchlight Loan Services, LLC has been appointed as the successor special servicer for the Prudential Plaza mortgage loan, effective October 14, 2026. Torchlight replaces CWCapital Asset Management LLC, which was terminated by the directing holder under the COMM 2015-CCRE26 Pooling and Servicing Agreement.
James D. Dee, Senior Vice President, General Counsel and Secretary, notified Carpenter Technology of his decision to retire effective December 31, 2026. The company has appointed Jed S. Freeman, the current Deputy General Counsel, to succeed him as Vice President, General Counsel and Secretary effective January 1, 2027.
David Safran resigned as a director of Compass Minerals International, Inc. on October 9, 2026, which the Board of Directors accepted on October 14, 2026. Following the resignation, the Board voted to reduce its total size to eight members.
Datavault AI appointed Jeffrey Tirman to its Board of Directors, effective October 12, 2026, following the resignation of director Wendy Wilson. Mr. Tirman was designated by NYIAX, Inc. in connection with Datavault AI's recently completed acquisition of NYIAX and brings over 35 years of international investment management and corporate restructuring experience.
NeOnc Technologies appointed Ali Mohammad Ahmad Alabedin, Group Head of Islamic Banking at First Abu Dhabi Bank, to its Board of Directors as a Class I director. He succeeds Dr. Steven L. Giannotta, who resigned from the Board but will continue to serve on the company's Scientific Advisory Board. The appointment is intended to strengthen financial governance as the company expands its clinical development activities in Abu Dhabi.
Halliburton Company appointed David C. Hernandez, President and Director of Hunt Consolidated, Inc., to its Board of Directors effective October 15, 2026. Mr. Hernandez will serve on the Audit Committee and the Health, Safety and Environment Committee, bringing extensive energy industry leadership and financial oversight expertise to the board.
Joseph P. Baratta notified the Board of Directors of his decision to resign as a director, effective December 31, 2026. The resignation coincides with his departure from Blackstone Inc. and is not due to any disagreement with the company's operations or policies.
Esther Song resigned as Vice President, Corporate Controller and Principal Accounting Officer, effective October 28, 2026. The company appointed Kermit Nolan, the current VP of Finance and former Chief Accounting Officer, to succeed her as Principal Accounting Officer. Ms. Song's departure was not due to any disagreements regarding company operations or accounting practices.
Joseph Baratta notified the board of his intention to resign as a director of Blackstone Inc. effective December 31, 2026, in connection with his planned retirement. Following his departure, the company will reduce the size of its board of directors from eight members to seven.
David B. Roberts notified the company of his intent to retire as President effective December 31, 2026, after 29 years of executive service. Mr. Roberts will continue to serve on the Board of Directors following his retirement as an employee.